CN112691124A - Application of endophytic fungus A814 extract in preparation of antibacterial drugs - Google Patents

Application of endophytic fungus A814 extract in preparation of antibacterial drugs Download PDF

Info

Publication number
CN112691124A
CN112691124A CN202011581189.XA CN202011581189A CN112691124A CN 112691124 A CN112691124 A CN 112691124A CN 202011581189 A CN202011581189 A CN 202011581189A CN 112691124 A CN112691124 A CN 112691124A
Authority
CN
China
Prior art keywords
fermentation
extract
liquidambaris
endophytic fungus
phomopsis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011581189.XA
Other languages
Chinese (zh)
Inventor
章卫民
许丽琼
李浩华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Detection Center of Microbiology of Guangdong Institute of Microbiology
Original Assignee
Guangdong Detection Center of Microbiology of Guangdong Institute of Microbiology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Detection Center of Microbiology of Guangdong Institute of Microbiology filed Critical Guangdong Detection Center of Microbiology of Guangdong Institute of Microbiology
Priority to CN202011581189.XA priority Critical patent/CN112691124A/en
Publication of CN112691124A publication Critical patent/CN112691124A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses application of an endophytic fungus A814 extract in preparation of antibacterial drugs. The invention discovers that the endophytic fungus Phomopsis liquidambaris A814 extract has obvious inhibiting effect on staphylococcus aureus and bacillus subtilis, and has good application and development prospect. Therefore, the invention provides a candidate drug for researching and developing a new antibacterial drug and provides a scientific basis for developing and utilizing natural active substances derived from endophytic fungi of plants.

Description

Application of endophytic fungus A814 extract in preparation of antibacterial drugs
Technical Field
The invention belongs to the technical field of biological medicines, and particularly relates to an application of an extract of Aquilaria malabaricus endophytic fungus Phomopsis liquidamb aris A814 in preparation of antibacterial drugs.
Background
At present, more and more drug-resistant strains of pathogenic microorganisms are discovered in clinical treatment, the infection is more and more serious, and a plurality of traditional antibiotics basically lose the treatment efficacy, so that the search for novel antibacterial drugs is a key field of new drug development in the world. The endophytic fungi can produce secondary metabolites with abundant structures, the structures of the secondary metabolites are the same as or similar to certain metabolites of a host, and the secondary metabolites have potential medicinal values, and the compounds with new structures discovered from the secondary metabolites become important resources for discovering natural active substances. The active products discovered in endophytic fungi of plants in recent years mainly have the structural types of terpenes, alkaloids, quinones, flavonoids, isocoumarins, lactones, lignans, phenols, polypeptides, steroids and the like, the biological activities of the metabolites have the biological activities of resisting tumors, bacteria, oxidation, malaria, viruses, insects, enzyme inhibitors, regulating plant growth and the like, and the metabolites have good application prospects in various fields of medicines, agriculture, industry and the like.
Disclosure of Invention
The invention aims to provide application of an endophytic fungus Phomopsis liquidambaris A814 extract in preparing antibacterial drugs.
The invention discovers that the diameters of inhibition zones of staphylococcus aureus (staphylococcus aureus) and Bacillus subtilis (Bacillus subtilis) are respectively 12mm and 11mm when the content of an endophytic fungus Bacillus liquidambaris A814 extract in each filter paper sheet is 10 mu g, and the diameters of the inhibition zones of positive control medicament ampicillin on the 2 test strains are respectively 18mm and 20mm under the same concentration; the experimental results show that: the extract of the endophytic fungus Phomopsis liquidambaris A814 has significant antibacterial activity. Therefore, the extract of endophytic fungus Phomopsis liquidambaris A814 can be used for preparing antibacterial drugs.
The antibacterial drug is preferably a drug for resisting staphylococcus aureus or bacillus subtilis.
The second object of the present invention is to provide an antibacterial agent comprising an extract of endophytic fungus Phomopsis liquidambaris A814 as an active ingredient.
The antibacterial drug is preferably a drug for resisting staphylococcus aureus and bacillus subtilis.
Preferably, the endophytic fungus Phomopsis liquidambaris A814 extract is obtained by taking the endophytic fungus Phomopsis liquidambaris A814 as a fermentation strain, performing liquid fermentation to obtain a fermentation culture, separating a mycelium and a fermentation broth, extracting the fermentation broth with ethyl acetate, and concentrating the extraction liquid to obtain the endophytic fungus Phomopsis liquidambaris A814 extract.
Preferably, the liquid fermentation is to inoculate endophytic fungus Phomopsis Liquidambaris A814 into a fermentation culture medium, and carry out liquid fermentation culture at 28 ℃ and 120r/min to obtain a fermentation culture, wherein the fermentation culture medium is prepared by the following method per liter: decocting potato 200g in distilled water for 20min, filtering to obtain juice, and adding glucose 20g and KH2PO43g、MgSO40.75g, vitamin B110mg, adding water to 1L, and naturally adjusting pH to obtain fermentation medium.
The invention discovers that the endophytic fungus Phomopsis liquidambaris A814 extract has obvious inhibiting effect on staphylococcus aureus and bacillus subtilis, and shows that the endophytic fungus Phomopsis liquidambaris A814 extract has better antibacterial activity, can be used for preparing antibacterial drugs, and has good application and development prospects. Therefore, the invention provides a candidate drug for researching and developing a new antibacterial drug and provides a scientific basis for developing and utilizing natural active substances derived from endophytic fungi of plants.
Phomopsis Liquidambaris A814 of the present invention was deposited at the Guangdong province culture Collection (GDMCC) at 12/9/2020 with addresses: the Guangzhou city first furious Zhonglu No. 100 large yard No. 59 building No. 5 building, the preservation number is: GDMCC No: 3.691, which were available to the depository at the filing date of this application.
Detailed Description
The present invention will be better understood by those skilled in the art from the following examples. The examples are described only to illustrate the invention and should not be construed as limiting the invention as detailed in the claims.
Activation, fermentation culture and extract preparation of strain A841(Phomopsis liquidambia)
(1) Inoculating endophytic fungus Phomopsis liquidambaris A814 to a slant culture medium, and culturing at 28 ℃ for 5d to obtain an activated strain. The slant culture medium is obtained by the following method: decocting potato 200g in distilled water for 20min, filtering to obtain juice, and adding glucose 20g and KH2PO43g、MgSO40.75g, vitamin B110mg of agar and 20g of water, the solution is made up to 1L with natural pH and sterilized for later use.
(2) Inoculating the activated and cultured strain A814 in the step (1) into a seed culture medium, and culturing for 7d at 28 ℃ under the condition of 120r/min oscillation to obtain a seed solution, wherein the seed culture medium is obtained by the following method: decocting potato 200g in distilled water for 20min, filtering to obtain juice, and adding glucose 20g and KH2PO43g、MgSO40.75g, vitamin B110mg, adding water to 1L, naturally adjusting pH, and sterilizing.
(3) Inoculating the seed liquid obtained in the step (2) into a fermentation culture medium in an inoculation amount of 10% (v/v), and culturing at 28 ℃ and 120r/min for 7d to obtain a fermentation culture. The fermentation medium is the same as the seed culture medium.
(4) Preparing an extract: and (3) filtering the fermentation culture obtained in the step (3) to remove mycelia, extracting the filtrate for 3 times by using ethyl acetate, and concentrating the extract under reduced pressure to obtain the endophytic fungus Phomopsis liquidambaris A814 extract.
Example 1: determination of Activity of endophytic fungus Phomopsis liquidambaris A814 extract against Staphylococcus aureus and Bacillus subtilis
The extract of the endophytic fungus Phomopsis liquidambaris A814 was dissolved in DMSO and diluted to a concentration of 2mg/mL to give a sample dilution.
Blending Staphylococcus aureus or Bacillus subtilis in logarithmic growth phase with normal saline to give a solution with a concentration of 106Absorbing 1mL of the prepared bacterial liquid from the CFU/mL bacterial liquid into a culture dish, pouring LB culture medium cooled to a proper temperature, uniformly mixing, clamping a filter paper sheet with the thickness of 1.5mm and the diameter of 6mm by using a sterile forceps, placing the filter paper sheet on a bacterial-containing flat plate, and respectively dropwise adding 5 mu L of the sample diluent on the filter paper sheetAs a sample group, DMSO was used as a blank control group instead of the sample diluent, ampicillin was used as a positive control group, the plate was incubated at 37 ℃ for 24 hours, and the diameter of the zone of inhibition was measured by a cross measurement method. Repeating the steps for three times, and calculating the average value of the diameters of the inhibition zones.
The results of the experiment are shown in table 1:
table 1: inhibition of bacteria by extract of endophytic fungus Phomopsis liquidambaris A814 ((
Figure BDA0002865968780000041
n=3)
Figure BDA0002865968780000042
The experimental results show that: the endophytic fungus Phomopsis liquidambaris A814 extract has obvious inhibition effect on staphylococcus aureus and bacillus subtilis and can be used for preparing medicines for resisting staphylococcus aureus and bacillus subtilis, so that the endophytic fungus Phomopsis liquidambaris A814 extract has wide application and development prospects in preparing antibacterial medicines.
The above is only a preferred embodiment of the present invention, and it should be noted that the above preferred embodiment should not be considered as limiting the present invention, and the protection scope of the present invention should be subject to the scope defined by the claims. It will be apparent to those skilled in the art that various modifications and adaptations can be made without departing from the spirit and scope of the invention, and these modifications and adaptations should be considered within the scope of the invention.

Claims (8)

1. Application of endophytic fungus Phomopsis liquidambaris A814 extract in preparing antibacterial drugs.
2. The application of claim 1, wherein the extract of endophytic fungus Phomopsis liquidambaris A814 is obtained by taking the endophytic fungus Phomopsis liquidambaris A814 as a fermentation strain, performing liquid fermentation to obtain a fermentation culture, separating mycelium and fermentation liquor, extracting the fermentation liquor with ethyl acetate, and concentrating the extract to obtain the extract of endophytic fungus Phomopsis liquidambaris A814.
3. The use according to claim 2, wherein the liquid fermentation is a fermentation culture obtained by inoculating the endophytic fungus Phomopsis liquidambaris A814 to a fermentation medium and performing liquid fermentation culture at 28 ℃ and 120r/min, wherein the fermentation medium is prepared by the following method per liter: decocting potato 200g in distilled water for 20min, filtering to obtain juice, and adding glucose 20g and KH2PO43 g、MgSO40.75g, vitamin B110mg, adding water to 1L, and naturally adjusting pH to obtain fermentation medium.
4. The use of claim 1, wherein said antibacterial agent is an agent against staphylococcus aureus or bacillus subtilis.
5. An antibacterial agent characterized by containing an extract of endophytic fungus Phomopsis liquidambaris A814 as an active ingredient.
6. The antibacterial drug according to claim 5, wherein the endophytic fungus Phomopsis liquidambaris A814 extract is obtained by taking the endophytic fungus Phomopsis liquidambaris A814 as a fermentation strain, performing liquid fermentation to obtain a fermentation culture, separating a mycelium and a fermentation broth, extracting the fermentation broth with ethyl acetate, and concentrating the extract to obtain the endophytic fungus Phomopsis liquidambaris A814 extract.
7. The antibacterial agent of claim 6, wherein the liquid fermentation is a fermentation culture obtained by inoculating Phomopsis liquidambaris A814 to a fermentation medium, and performing liquid fermentation at 28 ℃ and 120r/min, wherein each liter of the fermentation medium is prepared by the following method: decocting potato 200g in distilled water for 20min, and filtering to obtain juiceAdding 20g of glucose and KH2PO43 g、MgSO40.75g, vitamin B110mg, adding water to 1L, and naturally adjusting pH to obtain fermentation medium.
8. The antibacterial agent according to claim 5, wherein the antibacterial agent is an antibacterial agent against Staphylococcus aureus or Bacillus subtilis.
CN202011581189.XA 2020-12-28 2020-12-28 Application of endophytic fungus A814 extract in preparation of antibacterial drugs Pending CN112691124A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011581189.XA CN112691124A (en) 2020-12-28 2020-12-28 Application of endophytic fungus A814 extract in preparation of antibacterial drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011581189.XA CN112691124A (en) 2020-12-28 2020-12-28 Application of endophytic fungus A814 extract in preparation of antibacterial drugs

Publications (1)

Publication Number Publication Date
CN112691124A true CN112691124A (en) 2021-04-23

Family

ID=75511291

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011581189.XA Pending CN112691124A (en) 2020-12-28 2020-12-28 Application of endophytic fungus A814 extract in preparation of antibacterial drugs

Country Status (1)

Country Link
CN (1) CN112691124A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113956983A (en) * 2021-11-15 2022-01-21 浙江中医药大学 Atractylodes macrocephala endophytic fungus, fermentation product and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102154116A (en) * 2010-12-22 2011-08-17 浙江大化生物科技股份有限公司 Endophytic fungus Phomopsis sp. and use thereof
CN110862371A (en) * 2019-11-19 2020-03-06 广东省微生物研究所(广东省微生物分析检测中心) Polycyclic polyketone compound, preparation method thereof and application thereof in preparation of antibacterial drugs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102154116A (en) * 2010-12-22 2011-08-17 浙江大化生物科技股份有限公司 Endophytic fungus Phomopsis sp. and use thereof
CN110862371A (en) * 2019-11-19 2020-03-06 广东省微生物研究所(广东省微生物分析检测中心) Polycyclic polyketone compound, preparation method thereof and application thereof in preparation of antibacterial drugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
冉雪琴等: "罗汉松内生真菌的抑菌活性研究", 《中国畜牧兽医》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113956983A (en) * 2021-11-15 2022-01-21 浙江中医药大学 Atractylodes macrocephala endophytic fungus, fermentation product and application thereof
CN113956983B (en) * 2021-11-15 2023-07-11 浙江中医药大学 Endophytic fungus of bighead atractylodes rhizome, fermentation product and application thereof

Similar Documents

Publication Publication Date Title
US11459593B2 (en) Dendrobium officinale endophytic fungus strain and extracellular polysaccharide produced thereby, and extraction method and application of extracellular polysaccharide
Azcón Germination and hyphal growth of Glomus mosseae in vitro: effects of rhizosphere bacteria and cell-free culture media
CN111500644B (en) Preparation method of composite bacteria fermentation product for preventing and treating phytophthora root rot of plants, composite bacteria fermentation product and application of composite bacteria fermentation product
CN103131658B (en) Bacillus and application thereof in control of apple ring spot
CN102747020B (en) Bacillus subtilis and application thereof
CN103184184B (en) Streptomyces albidoflavus and applications thereof
CN110885776B (en) Cellulose streptomyces fermentation extract and application thereof
CN109266559B (en) A kind of application of Trichoderma harzianum LTR-2
CN107287246B (en) Marine fungus extract, preparation method and application
CN104342389A (en) Streptomyces strains and joint application thereof in prevention and treatment of cucumber fusarium wilt
CN112691124A (en) Application of endophytic fungus A814 extract in preparation of antibacterial drugs
CN104342388B (en) Streptomycete bacterial strain and prevent and treat tomato wilt use in conjunction
CN114946885B (en) Microbial pesticide for resisting leaf spot disease of polygonatum odoratum
CN112494522B (en) Application of endophytic fungus A871 extract in preparation of antibacterial drugs
CN116410890A (en) Environment-friendly actinomycetes SZF-179 and application thereof in pear black spot control
CN100412186C (en) Tinder fungus and process for deep liquid fermentation preparation of tinder fungus
CN114250176B (en) Preparation method and application of microbial agent for preventing and treating root rot of pseudo-ginseng
CN105543105A (en) Fungus strain capable of promoting salidroside accumulation of rhodiola crenulata and application of fungus strain
CN115851553A (en) Streptomyces virginiae capable of preventing and treating clubroot and application thereof
CN101914452B (en) Huperzine A high yield strain TCM-01
CN105695335A (en) New aspergillus flavus and use thereof
CN111406795B (en) Application of pleurotus citrinopileatus metabolite in preparation of aspergillus flavus bacteriostatic agent
CN104312948A (en) Streptomycete bacterial strains and combined application of Streptomycete bacterial strains for preventing and treating sclerotinia rot of colza
CN104293710A (en) Streptomycete strains and combined application thereof in prevention and treatment of pepper seedling blight
CN116064243B (en) Industrial cannabis endophytic fungus for producing cannabinol and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210423

RJ01 Rejection of invention patent application after publication